Somerville, MA, United States of America

Micha Sam Brickman Raredon


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Micha Sam Brickman Raredon: Innovator in Lung Bioreactor Technology

Introduction

Micha Sam Brickman Raredon is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of bioreactors for lung tissue. His innovative work aims to enhance the understanding and treatment of lung defects in large mammals.

Latest Patents

Raredon holds a patent for a "Human and large-mammal lung bioreactor." This invention provides a bioreactor specifically designed for large-mammal lung tissue. The bioreactor is capable of hydraulic-driven negative-pressure and positive-pressure perfusion and ventilation. It delivers perfusion and ventilation at physiological rates, which are easily controllable. One embodiment of the bioreactor includes a support scaffold to accommodate the size of large-mammal lung tissue. Another embodiment features a pleural sack that creates a small isolated fluid chamber surrounding an engineered lung, minimizing the amount of culture media required. This invention also offers an in vitro model for examining the function of test agents and methods for alleviating lung defects in large mammals.

Career Highlights

Throughout his career, Raredon has worked with prestigious institutions, including Yale University and Raredon Resources, Inc. His experience in these organizations has contributed to his expertise in the field of lung bioreactor technology.

Collaborations

Raredon has collaborated with notable individuals such as Tom Raredon and Laura E Niklason. These partnerships have likely enriched his research and development efforts in the biomedical field.

Conclusion

Micha Sam Brickman Raredon is a pioneering inventor whose work in lung bioreactor technology holds promise for advancing medical research and treatment options for lung defects in large mammals. His contributions to the field are significant and continue to inspire innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…